ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)
Condition(s):Hemophilia A; Congenital Factor VIII (FVIII) DeficiencyLast Updated:March 17, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Hemophilia A; Congenital Factor VIII (FVIII) DeficiencyLast Updated:March 17, 2021Completed
Condition(s):Hemophilia ALast Updated:October 12, 2016Unknown status
Condition(s):Hemophilia ALast Updated:August 9, 2016Completed
Condition(s):Joint DiseaseLast Updated:December 21, 2018Withdrawn
Condition(s):Hemophilia ALast Updated:April 26, 2022Recruiting
Condition(s):Severe Hemophilia ALast Updated:January 8, 2021Completed
Condition(s):Hemophilia ALast Updated:December 21, 2020Completed
Condition(s):Hemophilia ALast Updated:April 5, 2017Completed
Condition(s):Hemophilia ALast Updated:September 1, 2014Terminated
Condition(s):Hemophilia ALast Updated:February 10, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.